Epoetin beta

DB19434InvestigationalProtein Based Therapies

Epoetin beta: Overview.

Mechanism: Pharmacologically active on Erythropoietin receptor
Curator reviewed
Also known as: 1-165-ERYTHROPOIETIN (HUMAN CLONE LHEPOFL13 PROTEIN MOIETY), GLYCOFORM .BETA. · EPOETIN BETA RDNA · NEORECORMON · RECORMON
Code names: BM-06019

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

54Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Epoetin beta, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.